NCT06328088

Brief Summary

Earlier protein restriction was advocated in the treatment of HE but later this concept was refuted and increase protein intake was advocated in patients with HE. Diet in patients during an episode HE is also not known. It is advisable based on many case reports or case series that vegetable-based diet during the episode of HE is better than animal-based diet as it reduces ammonia level and other false neurotransmitters in brain and helps in early recovery of, HE . However, diet in patients who had recovered from an episode of, HE is not known and what type of protein (vegetarian or non-vegetarian) should be taken to prevent another episode of HE has never been evaluated. In India majority of the patients are vegetarian and patients with cirrhosis are malnourished and lack protein in their diet as per our previous published study

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 16, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 17, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 25, 2024

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2024

Completed
Last Updated

March 25, 2024

Status Verified

March 1, 2024

Enrollment Period

2 months

First QC Date

March 17, 2024

Last Update Submit

March 17, 2024

Conditions

Keywords

Hepatic encephalopathy;diet;vegetarian;non vegetarian;cirrhosis

Outcome Measures

Primary Outcomes (1)

  • Recurrence of overt hepatic encephalopathy

    6 month follow up

Secondary Outcomes (1)

  • Hospitalization due to any cause

    six month

Study Arms (2)

Non vegetarian diet

Non vegetarian diet

Dietary Supplement: Non vegetarian

Vegetarian diet

Vegetarian diet

Dietary Supplement: Non vegetarian

Interventions

Non vegetarianDIETARY_SUPPLEMENT

Non vegetarian diet plus supportive treatment including lactulose and/or rifaximin

Non vegetarian dietVegetarian diet

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients of cirrhosis and hepatic encephalopathy who has completely recovered from Hepatic encephalopathy and put on secondary prophylaxis

You may qualify if:

  • \- 1) Age 18 years and older. 2) Confirmed diagnosis of liver cirrhosis. (Diagnosed on the basis of clinical, biochemical, radiological or endoscopic features).
  • \) Willingness to sign informed consent proforma. 4) Patients who recovered from Hepatic encephalopathy will be enrolled from Out patient Department within 15 days of discharge

You may not qualify if:

  • \- 1) Patients with underlying severe cardiopulmonary disease or hepatocellular carcinoma.
  • \) Patients with CTP score of more than 12 3) Patient not willing for follow up or consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sir Ganga Ram Hospital

Delhi, 110060, India

RECRUITING

MeSH Terms

Conditions

Hepatic Encephalopathy

Condition Hierarchy (Ancestors)

Liver FailureHepatic InsufficiencyLiver DiseasesDigestive System DiseasesBrain Diseases, MetabolicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Praveen Sharma, MD,DM

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 17, 2024

First Posted

March 25, 2024

Study Start

February 16, 2024

Primary Completion

April 16, 2024

Study Completion

October 16, 2024

Last Updated

March 25, 2024

Record last verified: 2024-03

Locations